Clinical Trial: Phase 3 Pivotal Trial Comparing CARTISTEM(R) and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07339111) titled 'Phase 3 Pivotal Trial Comparing CARTISTEM(R) and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis' on Jan. 09.

Brief Summary: To establish the efficacy and safety of CARTISTEM(R), a combination product composed of allogeneic human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) formulated with a cross-linked sodium hyaluronate (HA) hydrogel, CARTISTEM(R) compared to the surgical comparator of debridement in Subjects with knee cartilage lesions and osteoarthritis.

This trial is intended to provide evidence of the superiority of CARTISTEM(R) to reduce knee pain and improve knee function compared to de...